相关实验视频

Updated: Jan 10, 2026

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril

Published on: October 3, 2020

库库比图里尔与中性客体瓦卢比辛的宿主-客体复合物:一个实验和计算研究

Yara N Al-Shdifat¹, Yazan H Akkam¹, Abdel-Monem M Rawashdeh²

¹Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan.

Drug development and industrial pharmacy

|November 25, 2025

概括

抗瘤药物瓦卢比辛 (VAL) 面临着溶解性和稳定性的问题. 黄瓜 (CBs) 与VAL形成稳定的复合物,显著改善其溶解性和稳定性,用于增强癌症治疗.

科学领域:

药物输送系统药物输送系统
超分子化学超分子化学
癌症治疗方法癌症治疗方法

背景情况:

瓦鲁比辛 (VAL) 是一种环素衍生物,表现出抗瘤活性,但其水溶性较差和不稳定.
这些局限性阻碍了其治疗疗效和临床应用.

研究的目的:

在水溶液中增强瓦鲁比辛 (VAL) 的物理化学特性.
作为一种潜在的药物输送策略,研究VAL与不同库库比图里尔 (CB) 的复杂化.

主要方法:

使用捕获效率 (EE) 进行复杂的形成和表征.
用UV-Vis定位,分子动力学 (MD) 和量子力学 (QM) 模拟来分析结合相互作用.
在体外药物释放研究和在不同温度下稳定性评估.

主要成果:

VAL与CBs形成了稳定的1:1宿主-客体复合体,显示出显著的结合亲和力.
分子建模证实了VAL在CB腔内部分包含.
该VAL-CB复合物实现了220,000倍的可溶性增加,增强稳定性和持续的药物释放.

结论:

黄瓜素 (CB7和CB8) 有效地增强水溶液中的瓦鲁比辛 (VAL) 的物理化学特性.
CB-VAL复合体显示出潜力,作为新型药物输送系统,用于疏水性药物.
这种方法为克服癌症治疗中的溶解化挑战提供了一个有希望的策略.

关键词:

人类循环类药物.分子动力学分子动力学有控制释放的释放.库库尔比图里尔是一种.东道主与客人的综合体.可溶性增强提高可溶性瓦鲁比辛是一种

更多相关视频

Heterogeneous Removal of Water-Soluble Ruthenium Olefin Metathesis Catalyst from Aqueous Media Via Host-Guest Interaction

Heterogeneous Removal of Water-Soluble Ruthenium Olefin Metathesis Catalyst from Aqueous Media Via Host-Guest Interaction

Published on: August 23, 2018

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

相关概念视频

Complexation Equilibria: The Chelate Effect

Complexation Equilibria: The Chelate Effect

In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...